121st Maine Legislature
		Office of Fiscal and Program Review
		LD 254
		An Act To Require Full Disclosure of Prescription Drug Marketing Costs
		LR 0072(01)
		Fiscal Note for Original Bill
		Sponsor: Rep. Kane
		Committee: Health and Human Services
		Fiscal Note Required: Yes
Fiscal Note
Undetermined current biennium cost increase - Other Special Revenue Funds
Undetermined current biennium revenue increase - Other Special Revenue Funds
Minor cost increase - General Fund
Minor revenue increase - General Fund
Correctional and Judicial Impact Statements
	Establishes new civil violation
Fiscal Detail and Notes
	Any initial start-up costs to the Bureau of Medical Services in the Department of Human Services can be absorbed within existing budgeted resources.  The bill requires prescription drug manufacturers pay fees to the Department in addition to submitting reports.  The amount of these fees are to be determined by the Department.  The timing and amount of revenue collected from these fees, as well as the ongoing costs of the Department can not be determined at this time.   The bill assumes the fees will be sufficient to cover additional costs to the Department.  Any additional costs to the Office of the Attorney General can be absorbed within existing budgeted resources.